PlainRecalls
FDA Devices Moderate Class II Terminated

Atrium ADVANTA VXT Vascular Graft, Part No. 22059, UDI 00650862220599 - Product Usage: intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.

Reported: October 6, 2021 Initiated: August 25, 2021 #Z-2589-2021

Product Description

Atrium ADVANTA VXT Vascular Graft, Part No. 22059, UDI 00650862220599 - Product Usage: intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.

Reason for Recall

The product package may potentially contain a mismatched graft that does not contain the radial support ring (helix) identified in the labeling.

Details

Units Affected
28 units
Distribution
Worldwide distribution - US Nationwide distribution in the state of Florida and the countries of South Korea and Poland.
Location
Merrimack, NH

Frequently Asked Questions

What product was recalled?
Atrium ADVANTA VXT Vascular Graft, Part No. 22059, UDI 00650862220599 - Product Usage: intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.. Recalled by Atrium Medical Corporation. Units affected: 28 units.
Why was this product recalled?
The product package may potentially contain a mismatched graft that does not contain the radial support ring (helix) identified in the labeling.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 6, 2021. Severity: Moderate. Recall number: Z-2589-2021.